The 17 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 83.00, with a high estimate of 90.00 and a low estimate of 60.00. The median estimate represents a +3.83% increase from the last price of 79.94.
The current consensus among 22 polled investment analysts is to Hold stock in Bristol-Myers Squibb Co. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.74
Reporting Date Feb 02
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.